Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Planned sale President sold 15,000 shares at $138.16 ($2,072,400)
  2. 4 Other acquisition Chief Executive Officer acquired 26,840 shares (other)
  3. 4 Planned sale Director sold 15,000 shares at an average $147.20 ($2,208,071)
  4. 4 Open-market sale Director sold 202,832 shares at an average $148.34 ($30,087,339)
  5. 4 Planned sale Chief Legal Officer sold 5,178 shares at $148.09 ($766,785)
  6. 4 Planned sale Director sold 15,000 shares at an average $151.25 ($2,268,804)
  7. 4 Planned sale Chief Financial Officer sold 691 shares at $140.72 ($97,237)
  8. 4 Planned sale President sold 339 shares at $140.72 ($47,704)
  9. 4 Planned sale Chief Legal Officer sold 122 shares at $140.72 ($17,168)
  10. 4 Planned sale Director sold 20,000 shares at an average $145.08 ($2,901,585)
  11. 4 Planned sale Chief Financial Officer sold 183 shares at $144.50 ($26,444)
  12. 4 Planned sale Chief Legal Officer sold 183 shares at $144.50 ($26,444)
  13. 4 Planned sale President sold 341 shares at $144.50 ($49,276)
  14. 4 Planned sale Chief Financial Officer sold 648 shares at $162.47 ($105,283)
  15. 4 Planned sale Chief Legal Officer sold 1,296 shares at $162.47 ($210,566)
  16. 4 Planned sale Director sold 15,000 shares at an average $157.57 ($2,363,556)
  17. 4 Planned sale Director sold 15,000 shares at an average $127.32 ($1,909,863)
  18. 4 Planned sale President sold 15,000 shares at $127.49 ($1,912,350)
  19. 4 Planned sale President sold 255 shares at $120.96 ($30,844)
  20. 4 Planned sale Director sold 15,000 shares at an average $121.68 ($1,825,220)

Page 8 of 54 · 1,067 filings